The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of PSMA PET/CT on prostate cancer salvage radiotherapy management: Results from the prospective randomized phase 3 trial [PSMA SRT NCT03582774].
 
Wesley R Armstrong
No Relationships to Disclose
 
Amar Upadhyaya Kishan
Stock and Other Ownership Interests - ViewRay
Honoraria - Varian Medical Systems; ViewRay; ViewRay
Consulting or Advisory Role - Janssen
Research Funding - ViewRay; ViewRay
 
Kiara M Booker
No Relationships to Disclose
 
Wolfgang Peter Fendler
Honoraria - Parexel
Consulting or Advisory Role - Calyx; Janssen
Speakers' Bureau - Bayer; Janssen
Research Funding - SOFIE
 
Thomas A. Hope
Stock and Other Ownership Interests - RayzeBio
Honoraria - GE Healthcare
Consulting or Advisory Role - Blue Earth Diagnostics; Curium Pharma; Ipsen
Research Funding - Advanced Accelerator Applications (Inst); Clovis Oncology (Inst); GE Healthcare (Inst); Philips Healthcare (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Nicholas George Nickols
No Relationships to Disclose
 
Johannes Czernin
Leadership - SOFIE; Trethera
Stock and Other Ownership Interests - RayzeBio; SOFIE; Trethera
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; RayzeBio
 
Jeremie Calais
Honoraria - Advanced Accelerator Applications; EXINI Diagnostics; Progenics; Radiomedix
Consulting or Advisory Role - Blue Earth Diagnostics; Curium Pharma; GE Healthcare; Janssen; Lantheus Medical Imaging; POINT Biopharma; Progenics; Telix Pharmaceuticals
Speakers' Bureau - IBA RadioPharma Solutions; Telix Pharmaceuticals
Research Funding - Progenics